Literature DB >> 9787348

The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age.

B Lindblom1, T Andersson.   

Abstract

OBJECTIVE: To examine the prognosis of idiopathic choroidal neovascular membranes in patients younger than 50 years of age at the time of diagnosis.
DESIGN: Retrospective noncomparative case series. PARTICIPANTS: Eighteen consecutive patients from a university clinic (20 eyes) with idiopathic choroidal neovascularization in the macular area. All patients diagnosed between 1979 and 1996 were included; follow-up time varied from 5 to 187 months (mean, 55 months). INTERVENTION: Treatment was conservative. All patients were informed about argon laser photocoagulation, but in the majority of cases, patients were not encouraged to undergo such treatment. Treatment was given on patient's request. MAIN OUTCOME MEASURES: The dimensions of the choroidal neovascular membrane and its distance to the foveola were determined by computerized image analysis and their correlation with final visual acuity determined.
RESULTS: Fifteen (75%) of the 20 eyes retained a visual acuity of 20/60 or better. In ten eyes (50%), acuity was 20/25 or better. Six eyes had been treated with laser photocoagulation; only one had a membrane located 200 microns or more from the foveola at the time of treatment. The outcome for treated eyes was no better than for untreated eyes, although the two groups were not directly comparable. In no eye did an initially juxtafoveal or extrafoveal membrane continue to grow under the foveola.
CONCLUSIONS: The prognosis of idiopathic choroidal neovascularization was much better than reported previously for eyes with choroidal membranes associated with age-related macular degeneration. A conservative treatment regimen should be considered. The authors have no reason to believe that laser photocoagulation would have improved the outcome in the nontreated eyes.

Entities:  

Mesh:

Year:  1998        PMID: 9787348     DOI: 10.1016/S0161-6420(98)91021-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  [Photodynamic treatment with verteporfin for patients with idiopathic choroidal neovascularization. Two-year results].

Authors:  J Wachtlin; A Wehner; H Heimann; M H Foerster
Journal:  Ophthalmologe       Date:  2004-05       Impact factor: 1.059

2.  A case of idiopathic choroidal neovascular membrane in a young patient.

Authors:  M A Khan; Shabnam Bhalla; V S Gurunadh; V K Mohindra; Sridhara Reddy
Journal:  Med J Armed Forces India       Date:  2015-02-16

3.  Idiopathic choroidal neovascularisation in pregnancy: treatment options and a successful outcome.

Authors:  Samantha Roshani De Silva; Farhat Bibi; Kuan Sim; Mandeep Singh Bindra
Journal:  BMJ Case Rep       Date:  2016-07-19

4.  Occult inflammation detected by autofluorescence May Be the cause of idiopathic choroidal neovascularization.

Authors:  Luiz H Lima; Claudio Zett; Marcelo B Casella; Felipe Pereira; Eduardo B Rodrigues; Deepika C Parameswarappa; Jay Chabblani
Journal:  Am J Ophthalmol Case Rep       Date:  2020-10-17

5.  Orange ring sign: A novel finding on multicolor imaging in eyes with idiopathic choroidal neovascular membrane.

Authors:  Rupak Roy; Kumar Saurabh; Sugandha Goel
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

Review 6.  Photodynamic therapy in macular diseases of asian populations: when East meets West.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Yasuo Tano; David T L Liu; Kenneth K W Li; Dennis S C Lam
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.211

7.  Idiopathic choroidal neovascular membrane in a young female.

Authors:  Saad Abdullah Waheeb; Mahmood Jameel Showail
Journal:  Oman J Ophthalmol       Date:  2009-09

8.  Peripapillary Neovascular Membrane in a Young Pregnant Woman and Prompt Response to Ranibizumab Injections following Uneventful Delivery.

Authors:  Konstantinos Anastasilakis; Chrysanthos Symeonidis; Konstantinos Kaprinis; Asimina Mataftsi; Argyrios Tzamalis; Stavros A Dimitrakos
Journal:  Case Rep Ophthalmol       Date:  2011-04-22

9.  Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization.

Authors:  Qianru Wu; Xiaoyong Chen; Kang Feng; Yuling Liu; Chun Zhang; Lin Zhao
Journal:  BMC Ophthalmol       Date:  2020-03-19       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.